In vitro experiments showed that BTS may achieve depression-inducing effects by downregulating Nos-2 and Cox-2 to inhibit NO production, stimulating pro-inflammatory cytokine production and inducing neuroinflammatory responses in microglia. This evidence concerns the gene PTGS2 and depressive disorder.